We hypothesize that a disruption in the trafficking of glucagon and Stmn2 through the endolysosomal pathway might be a possible mechanism by which glucagon secretion becomes dysregulated in diabetes, resulting in glucagon hypersecretion and hyperglucagonemia. The gene discussed is STMN2; the disease is diabetes mellitus.